Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Head and Neck Neoplasms × ribociclib × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Glioma 3 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Endocrine Neoplasia Type 1 2 Melanoma 2 Diffuse Intrinsic Pontine Glioma 2 Thymus Neoplasms 1 Teratoma 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Osteitis Deformans 1 Non functioning pancreatic endocrine tumor 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Mesothelioma 1 Medulloblastoma 1 Lymphoma 1 Leukemia 1 Hematologic Neoplasms 1 Glioblastoma 1 Familial ependymoma 1 Fallopian Tube Neoplasms 1 Estrogen Receptor and/or Progesterone Receptor Positive 1 Cystadenocarcinoma, Serous 1 Breast Neoplasms, Male 1

Interventions

Cisplatin 60 Cetuximab 51 Radiotherapy 34 pembrolizumab 26 Radiotherapy, Intensity-Modulated 23 Carboplatin 21 Docetaxel 19 Paclitaxel 18 Fluorouracil 17 Pemetrexed 9 Erlotinib Hydrochloride 9 Nivolumab 8 Gemcitabine 8 Radiation 7 Drug Therapy 7 Bevacizumab 7 durvalumab 6 Panitumumab 6 Everolimus 6 epacadostat 5 Surgical Procedures, Operative 5 Standard of Care 5 Lapatinib 5 Gefitinib 5 Albumin-Bound Paclitaxel 5 130-nm albumin-bound paclitaxel 5 Oxaliplatin 4 Ipilimumab 4 Cyclophosphamide 4 Celecoxib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡